KSKaren M. Stechuchak

Karen M. Stechuchak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karen M. Stechuchak has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Associations Between Social Drivers of Health and Intervention Reach During Implementation of a Supervised Walking Program

    by Sarah M. Wilson, Akanksha Das, Kaileigh Byrd, Caitlin B. Kappler, Karen M. Stechuchak, Greeshma Thomas, Tiff. A. Beaver, Maren K. Olsen, Kimberly S. Johnson, Courtney Van Houtven, et al.

    Objective: To examine associations between social drivers of health and veteran-level reach of STRIDE, a supervised walking program implemented in the Veterans Health Administration (VA). Study Setting and Design: We included 2527 patients across 5 facilities. We tested whether housing insecurity, rurality, race, and neighborhood deprivation were associated with reach, defined as any STRIDE walk during hospitalization. Data Sources and Analytical Sample: We used the first 6 months of postimplementation data from a stepped-wedge implementation trial. Principal Findings: During the implementation period, 197 veterans (7.8%) received at least 1 STRIDE walk. In unadjusted models, patients residing rurally (vs. urban) and those who were White, non-Hispanic/Latino (NH) (vs. Black NH) were significantly more likely to receive ≥1 STRIDE walk. Unadjusted models showed large site differences in STRIDE reach, ranging from 3% to 26% probability by site. Reach differences coincided somewhat with facility-level racial composition: the lowest reach was observed at a site with a majority of Black NH admitted patients, whereas the highest reach was found at a site with a majority of White NH patients. In adjusted models, patient-level rurality remained associated with greater reach (probability 9% for rural veterans vs. 6% for urban veterans), but race was no longer associated (probability 6% among White NH veterans vs. 7% among Black NH veterans). Conclusions: Patient-level rurality was consistently positively associated with implementation outcomes. Patient-level race was associated with implementation outcomes in unadjusted but not adjusted models. Secondary analyses in implementation trials may help assess how social drivers of health are associated with implementation outcomes.

  • The STRIDE Program: Getting Hospitalized Veterans Back on Their Feet

    by Susan N. Hastings, Ashley Choate, Caitlin B. Kappler, Karen M. Stechuchak, Cassie Meyer, Cynthia J. Coffman


  • Open Access

    Implementation of a stepped wedge cluster randomized trial to evaluate a hospital mobility program

    by Susan N. Hastings, Karen M. Stechuchak, Ashley Choate, Elizabeth P. Mahanna, Courtney Van Houtven, Kelli D. Allen, Virginia Wang, Nina Sperber, Leah Zullig, Hayden B. Bosworth, et al.

    Background: Stepped wedge cluster randomized trials (SW-CRT) are increasingly used to evaluate new clinical programs, yet there is limited guidance on practical aspects of applying this design. We report our early experiences conducting a SW-CRT to examine an inpatient mobility program (STRIDE) in the Veterans Health Administration (VHA). We provide recommendations for future research using this design to evaluate clinical programs. Methods: Based on data from study records and reflections from the investigator team, we describe and assess the design and initial stages of a SW-CRT, from site recruitment to program launch in 8 VHA hospitals. Results: Site recruitment consisted of thirty 1-h conference calls with representatives from 22 individual VAs who expressed interest in implementing STRIDE. Of these, 8 hospitals were enrolled and randomly assigned in two stratified blocks (4 hospitals per block) to a STRIDE launch date. Block 1 randomization occurred in July 2017 with first STRIDE launch in December 2017; block 2 randomization occurred in April 2018 with first STRIDE launch in January 2019. The primary study outcome of discharge destination will be assessed using routinely collected data in the electronic health record (EHR). Within randomized blocks, two hospitals per sequence launched STRIDE approximately every 3 months with primary outcome assessment paused during the 3-month time period of program launch. All sites received 6–8 implementation support calls, according to a pre-specified schedule, from the time of recruitment to program launch, and all 8 sites successfully launched within their assigned 3-month window. Seven of the eight sites initially started with a limited roll out (for example on one ward) or modified version of STRIDE (for example, using existing staff to conduct walks until new positions were filled). Conclusions: Future studies should incorporate sufficient time for site recruitment and carefully consider the following to inform design of SW-CRTs to evaluate rollout of a new clinical program: (1) whether a blocked randomization fits study needs, (2) the amount of time and implementation support sites will need to start their programs, and (3) whether clinical programs are likely to include a “ramp-up” period. Successful execution of SW-CRT designs requires both adherence to rigorous design principles and also careful consideration of logistical requirements for timing of program roll out. Trial registration: ClinicalsTrials.gov NCT03300336. Prospectively registered on 3 October 2017.


  • Open Access

    Comparison of outcomes for veterans receiving dialysis care from VA and non-VA providers

    by Virginia Wang, Matthew L Maciejewski, Uptal D Patel, Karen M Stechuchak, Denise M Hynes, Morris Weinberger

    Demand for dialysis treatment exceeds its supply within the Veterans Health Administration (VA), requiring VA to outsource dialysis care by purchasing private sector dialysis for veterans on a fee-for-service basis. It is unclear whether outcomes are similar for veterans receiving dialysis from VA versus non-VA providers. We assessed the extent of chronic dialysis treatment utilization and differences in all-cause hospitalizations and mortality between veterans receiving dialysis from VA versus VA-outsourced providers.